This study mainly explored the difference in the positive rate of the EML4-ALK fusion gene detected by different methods and in different samples, and this study provided a basis for the selection of methods for detecting driver genes in clinical NSCLC patients. Here, EML4 is linked to non-small cell lung carcinoma.